glp-1 during pregnancy medications like Ozempic, Wegovy and Mounjaro are changing diabetes and weight management, but they aren't recommended or while nursing. The current recommendation is to stop before conception and discuss Maternal GLP-1 receptor activation inhibits

The result: balanced appetite cues and everyday metabolic wellness, all powered by nutritionnot drugs.*

GLP-1 receptor agonist initiation was associated with a reduced risk for exacerbation in the morbidly obese group, with a risk ratio of 0.780 and risk difference of 13.3 percent."Asthma exacerbations can be disruptive for patients, especially those living with obesity, who often have fewer effective treatment options," Patel said in a statement

Br J Pharmacol 130:351358 Jendle J, Nauck MA, Matthews DR et al (2009) Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue

Security requirements and clinical-system integration can lengthen implementation

The medication comes in both branded pen form (Wegovy for weight loss, Ozempic for diabetes) and compounded vial form

Litsa Lambrakos joined leaders in cardiac electrophysiology to rethink how to care for people with persistent atrial fibrillation